|1.||Niederhofer, Helmut: 5 articles (03/2010 - 05/2003)|
|2.||Kim, Woong Mo: 3 articles (06/2015 - 03/2012)|
|3.||Yoon, Myung Ha: 3 articles (06/2015 - 03/2012)|
|4.||Kayir, Hakan: 3 articles (02/2007 - 03/2005)|
|5.||Rumiantseva, G M: 3 articles (01/2006 - 01/2003)|
|6.||Ha, Jee Hyun: 2 articles (10/2015 - 04/2014)|
|7.||Fava, Maurizio: 2 articles (10/2015 - 04/2014)|
|8.||Jeon, Hong Jin: 2 articles (10/2015 - 04/2014)|
|9.||Lee, Seung-Hwan: 2 articles (10/2015 - 04/2014)|
|10.||Chung, Seockhoon: 2 articles (10/2015 - 04/2014)|
|1.||Depressive Disorder (Melancholia)
03/01/1995 - "Preliminary evidence suggests that tianeptine may also be effective in patients with endogenous depression. "
01/01/1988 - "The authors have concluded that tianeptine is effective in depressive disorders as shown both by depression rating scales and subjective impressions of treated patients. "
03/01/2010 - "Converging lines of evidences demonstrate actions of tianeptine on the glutamatergic system, and therefore offer new insights into how tianeptine may be useful in the treatment of depressive disorders."
06/01/2005 - "Together with clinical data on the efficacy of tianeptine as an antidepressant, these actions offer insights into how compounds like tianeptine may be useful in the treatment of neurobiological features of depressive disorders."
09/01/2011 - "The authors put forward the hypotheses that during a three-month treatment with tianeptine in patients with depressive disorders there is an improvement in the short-term memory, reaction time and attention. "
|2.||Post-Traumatic Stress Disorders (PTSD)
01/01/2005 - "The coaxil efficacy depended on a PTSD type: the drug was more effective in chronic PTSD that, in the authors' opinion, might be related to its antidepressant action."
01/01/2008 - "These studies lead to the conclusion that Coaxil is an effective agent for the treatment of different types of PTSD."
01/01/2006 - "It has been concluded that coaxil is an effective medication for the treatment of different PTSD types."
07/01/2013 - "These findings illustrate the differential effectiveness of these three treatments to block components of PTSD-like symptoms in rats, and in particular, reveal the profile of tianeptine as the most effective of all three agents."
09/01/2011 - "Tianeptine in the combined treatment of combat related posttraumatic stress disorder."
|3.||Major Depressive Disorder (Major Depressive Disorders)
01/01/2012 - "The combination of MAIOs and tianeptine may be effective for refractory major depressive disorder."
10/01/2013 - "In this paper, we present the use of tianeptine in eight American treatment-resistant patients with major depressive disorder. "
09/01/2003 - "The patient was hospitalised to treat both the addiction to tianeptine and the ongoing major depressive disorder. "
09/01/2003 - "Tianeptine was prescribed for a major depressive disorder. "
10/01/1997 - "Efficacy of tianeptine in major depressive disorders with or without melancholia."
|4.||Bipolar Disorder (Mania)
01/01/1996 - "These results confirmed the efficacy of tianeptine (37.5 mg/d) in the treatment of major depression and depressed bipolar disorder when compared to placebo. "
01/01/1997 - "After a 1-week run-in placebo period, 126 depressed out-patients presenting DSM-III-R Major Depression or Bipolar Disorder, Depressed, with a total MADRS score of at least 25, were treated for 42 days with either tianeptine (25-50 mg/day) or placebo. "
01/01/1996 - "Efficacy and safety of tianeptine were evaluated in 187 depressed inpatients (56% female, 44% male), who fulfilled criteria for either major depression, single episode (24.6%) or recurrent (66.8%), or depressed bipolar disorder (8.6%). "
03/01/1995 - "The antidepressant efficacy of tianeptine, as shown in 2 trials of patients with major depression or depressed bipolar disorder with or without melancholia, is greater than that of placebo. "
01/01/1997 - "The results confirmed the efficacy of tianeptine (mean dosage: 37.5 mg/day) in the treatment of Major Depression and Bipolar Disorder, Depressed, with or without melancholia, compared to placebo. "
05/01/1990 - "1,231 patients with a DSM III diagnosis of major depression or dysthymic disorder were included in a long-term trial with tianeptine. "
02/01/1992 - "This study evaluated the therapeutic efficacy and acceptability during long-term administration of tianeptine in depressed patients (major depressive episode or dysthymic disorder) in a multicentre trial, after withdrawal from alcohol abuse or dependence. "
01/01/1988 - "129 chronic alcoholic patients, withdrawn from alcohol and presenting major depression or dysthymic disorder, were treated for 4-8 weeks under double-blind conditions either with a new antidepressant, tianeptine (37.5 mg per day), or with amitriptyline (75 mg per day). "
02/01/1992 - "The clinical properties of tianeptine have been assessed in double-blind controlled studies, which involved depressed patients fulfilling DSM-III criteria for either major depression--single episode or recurrent (without melancholia and psychotic features)--or dysthymic disorder--with or without an additional diagnosis of alcohol abuse or dependence. "
03/01/1995 - "In patients with major depression without melancholia or psychotic features, depressed bipolar disorder or dysthymic disorder, the antidepressant efficacy of short term (4 weeks to 3 months) tianeptine therapy appears to be similar to that of amitriptyline, imipramine and fluoxetine and may be superior to that of maprotiline in patients with coexisting depression and anxiety. "
|1.||Serotonin (5 Hydroxytryptamine)
|7.||Serotonin Uptake Inhibitors (Serotonin Reuptake Inhibitors)
|9.||Morphine (MS Contin)